Dogwood Therapeutics, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -20.6% | -22.6% | +12.8% | -37.2% | +4,030.4% | +2.8% | -0.3% | -4.9% | -2.0% | +5.6% | -15.5% | |
| – | -20.6% | -22.6% | +12.8% | -37.2% | +624.6% | +15.8% | -23.3% | -20.7% | -27.7% | +78.0% | -26.5% | |
| – | -30.7% | -28.3% | +26.9% | -32.5% | +627.9% | +18.1% | -23.6% | -24.4% | -35.6% | +102.7% | -27.3% | |
| – | -30.7% | -28.3% | +26.9% | -32.5% | +627.9% | +18.1% | -23.6% | -24.4% | -35.6% | +102.7% | -27.3% | |
| – | – | – | – | – | – | +0.1% | +5.4% | -2.0% | +1.6% | -1.7% | -1.9% | |
| – | – | – | – | – | – | +18.1% | -10.7% | -2.0% | +1.6% | -1.7% | -15.5% | |
| – | -26.4% | +59.0% | -12.3% | +166.7% | +2,151.2% | +199.4% | -84.3% | +3.2% | +4.6% | -4.5% | -16.8% | |
| – | -26.4% | +59.0% | -12.3% | +166.7% | +138.1% | -18.8% | -26.9% | +37.7% | +17.8% | -16.3% | +10.6% | |
| – | – | – | – | – | – | +2.1% | +7.4% | +0.1% | +4.2% | +0.8% | +0.6% | |
| – | -45.5% | +75.8% | +10.7% | +108.9% | +170.7% | -6.3% | -56.8% | +17.4% | +30.2% | -81.0% | +185.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -20.1% | -30.3% | +18.1% | -69.7% | +6,670.5% | -89.0% | +1,064.7% | -6.2% | -3.2% | +7.6% | -15.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.9% | +0.0% | +18.9% | +21.2% | +18.0% | +10.0% | +0.0% | +33.2% | +656.5% | +131.0% | +1.7% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.